Diagnostic Ability and Capacity of Optical Coherence Tomography-Angiography to Detect Retinal and Vascular Changes in Patients with Fibromyalgia

Table 3

Macular structural analysis (in microns) of the retinal nerve fiber layer and the ganglion cell layer in patients with fibromyalgia and healthy subjects using swept-source Triton optical coherence tomography. Bold numbers indicate . The significance according to the Bonferroni’s correction was calculated as .

	Macular sector	FM (mean ± SD)	Controls (mean ± SD)
mRNFL	Superotemporal	25.06 ± 4.12	24.88 ± 2.00	0.779
	Superior	38.49 ± 5.39	39.00 ± 4.94	0.624
	Superonasal	45.67 ± 6.64	47.10 ± 5.25	0.245
	Inferonasal	70.71 ± 9.35	75.15 ± 10.08	0.563
	Inferior	40.74 ± 8.32	39.82 ± 4.67	0.500
	Inferotemporal	26.17 ± 2.73	26.19 ± 2.15	0.976
mGCL	Superotemporal	68.24 ± 8.25	71.99 ± 7.91	0.026
	Superior	70.39 ± 6.42	72.57 ± 8.50	0.168
	Superonasal	73.29 ± 7.24	76.53 ± 9.30	0.064
	Inferonasal	70.71 ± 9.35	75.15 ± 10.08	0.029
	Inferior	67.38 ± 6.71	70.28 ± 8.23	0.066
	Inferotemporal	70.41 ± 8.33	73.73 ± 8.12	0.053

FM, fibromyalgia; SD, standard deviation; mRNFL, macular retinal nerve fiber layer; mGCL, macular ganglion cell layer.